Roth Capital raised the firm's price target on eGain to $20 from $10 and keeps a Buy rating on the shares. The company's Q1 results were good, with revenues moderately above the firm's forecast, which allowed falling costs to translate into record adjusted EBITDA, the analyst tells investors in a research note. With AI-centric offerings appearing to offer a good intermediate-term growth acceleration path and its earnings step-up confirmed, the firm is more positive on the stock, Roth added.
